Deals
Centene to Acquire Magellan Health in $2.2 Billion Deal
- Insurer’s latest deal boosts behavioral health business
- Transaction expected to close in second half of 2021
This article is for subscribers only.
Insurer Centene Corp. agreed to buy Magellan Health Inc., in a transaction valuing the target company at $2.2 billion, to expand further into mental-health care.
Centene will pay $95 a share in cash, according to a statement on Monday, or 15% above Magellan Health’s closing price on Thursday. The purchase will be primarily funded with debt, and JPMorgan Chase & Co. has provided a bridge financing commitment.